Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design.
Tools
Sechaud, Romain, Graf, Peter, Bigler, Hilde, Gruendl, E, Letzkus, Martin and Merz, Michael (2002) Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design. International journal of clinical pharmacology and therapeutics, 40 (1). pp. 35-40. ISSN 0946-1965
Official URL: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retri...
Abstract
Two formulations of valsartan (Diovan), 320 mg tablets and marketed 160 mg capsules, were evaluated for bioequivalence after single dosing.
Item Type: | Article |
---|---|
Date Deposited: | 28 Jan 2012 00:45 |
Last Modified: | 01 Feb 2013 00:46 |
URI: | https://oak.novartis.com/id/eprint/5609 |